Meridian Management’s Marker Therapeutics MRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,956
Closed -$9K 81
2022
Q1
$9K Buy
+1,956
New +$9K ﹤0.01% 84
2021
Q2
Sell
-1,956
Closed -$44K 83
2021
Q1
$44K Buy
1,956
+175
+10% +$3.94K 0.01% 78
2020
Q4
$26K Hold
1,781
0.01% 79
2020
Q3
$27K Hold
1,781
0.01% 76
2020
Q2
$37K Buy
1,781
+131
+8% +$2.72K 0.02% 73
2020
Q1
$31K Buy
1,650
+475
+40% +$8.92K 0.01% 66
2019
Q4
$34K Buy
+1,175
New +$34K 0.01% 75